[Jinling Pharmaceutical Co., Ltd.: branch receives notice of acceptance of magnesium Sulfate injection] June 7, Jinling Pharmaceutical Co., Ltd., Jinling Pharmaceutical Co., Ltd., Nanjing Jinling Pharmaceutical Factory recently received a notice of acceptance of magnesium sulfate injection issued by the State Drug Administration. In clinic, magnesium sulfate injection can be used as an anticonvulsant for pregnancy induced hypertension, to reduce blood pressure and to treat preeclampsia and eclampsia. If magnesium sulfate injection can be successfully put on the market, it will be regarded as passing the quality consistency evaluation and enriching the company's product pipeline.